During the past decade, Ospedale San Carlo; Day Hospital Oncologia Medica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Carlo; Day Hospital Oncologia Medica" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Carlo; Day Hospital Oncologia Medica" are "Breast Cancer" (2 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "Ospedale San Carlo; Day Hospital Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Ospedale San Carlo; Day Hospital Oncologia Medica" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "Trastuzumab" (2 trials), "Atezolizumab" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Carlo; Day Hospital Oncologia Medica" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale San Carlo; Day Hospital Oncologia Medica". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ospedale San Carlo; Day Hospital Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Carlo; Day Hospital Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".